Document Detail

Cellular cardiomyoplasty in acute myocardial infarction: where are we now?
MedLine Citation:
PMID:  18440658     Owner:  NLM     Status:  MEDLINE    
Cellular cardiomyoplasty is an investigational technique that may have the potential to reduce myocardial infarct size and improve cardiac function in patients with ischemic heart disease. However, experience with this approach is still limited to a few small trials, some of which were not blinded or had other design problems. The mechanism of benefit, long-term safety, and clinical efficacy of cellular cardiomyoplasty require further study.
Turgay Celik; Atila Iyisoy; U Cagdas Yuksel; Ersoy Isik
Related Documents :
2485068 - Converting-enzyme inhibition in the management of severe chronic congestive heart failu...
25485348 - First report on long-term clinical results after treatment of coronary bifurcation lesi...
25440788 - Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the curren...
12594448 - The problem of decompensated heart failure: nomenclature, classification, and risk stra...
16018378 - Foley catheter and deep hypothermic circulatory arrest to control bleeding in redo card...
832288 - Reactive hyperaemia in the dog heart: evidence for a myogenic contribution.
Publication Detail:
Type:  Comment; Letter     Date:  2008-04-28
Journal Detail:
Title:  International journal of cardiology     Volume:  135     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-02     Completed Date:  2009-08-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  111-4; author reply 115-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Combined Modality Therapy
Granulocyte Colony-Stimulating Factor / therapeutic use*
Myocardial Infarction / therapy*
Treatment Outcome
Reg. No./Substance:
143011-72-7/Granulocyte Colony-Stimulating Factor
Comment On:
Int J Cardiol. 2007 Oct 31;122(1):41-7   [PMID:  17182126 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of specific serotonin reuptake inhibitors (SSRIs) (Sertraline or Citalopram) in the treatment of...
Next Document:  Assessing a landscape barrier using genetic simulation modelling: implications for raccoon rabies ma...